Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Testosterone-Guided Schedule of Androgen Deprivation Therapy (ADT) as an Alternative to A Fixed Schedule In Management Of Prostate Cancer

NCT01056562 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT01056562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01056562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Testosterone-Guided Schedule of Androgen Deprivation Therapy (ADT) as an Alternative to A Fixed Schedule In Management Of Prostate Cancer
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Completed
Start date
November 30, 2009
Completion date
June 30, 2014
Enrollment
82 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer